Antibody Tests Clinical Trials

• Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00009776 - Active, not recruiting
  Burkitt's Lymphoma; Lymphocytic Lymphoma
  
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
  recurrent neuroblastoma
  
• Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006347 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003478 - Active, not recruiting
  adult brain tumor
  
• Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00008021 - Active, not recruiting
  Burkitt's Lymphoma; Lymphoblastic Lymphoma; Myeloid Leukemia
  
• beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00037011 - Active, not recruiting
  disseminated neuroblastoma; recurrent neuroblastoma
  
• Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
  ClinicalTrials.gov Identifier: NCT00089245 - Recruiting
  Cancer
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003082 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00028613 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00005813 - Active, not recruiting
  adult glioblastoma multiforme
  
• Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003484 - Active, not recruiting
  Central Nervous System Tumor; Brain Tumor
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00027729 - Active, not recruiting
  recurrent colon cancer; recurrent rectal cancer
  
• Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00058396 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia
  
• Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00004110 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00024232 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00003023 - Active, not recruiting
  childhood soft tissue sarcoma; Muscle Cancer; Neuroblastoma; Osteosarcoma
  
• Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006352 - Active, not recruiting
  limited stage small cell lung cancer
  
• Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003337 - Active, not recruiting
  Lymphoma
  
• Monoclonal Antibody Therapy Plus Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005940 - Active, not recruiting
  adult acute myeloid leukemia in remission
  
• Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
  ClinicalTrials.gov Identifier: NCT00004017 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma
  
• CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00090896 - Active, not recruiting
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00039273 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00004177 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00047151 - Active, not recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003963 - Active, not recruiting
  Waldenstrom's Macroglobulinemia; adult non-Hodgkin's lymphoma
  
• Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003920 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028483 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00004879 - Active, not recruiting
  Colorectal Cancer; Esophageal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; Prostate Cancer
  
• Chemotherapy With or Without Monoclonal Antibody in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012285 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00045617 - Active, not recruiting
  limited stage small cell lung cancer
  
• Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
  ClinicalTrials.gov Identifier: NCT00066547 - Active, not recruiting
  recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00012233 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer
  
• Monoclonal Antibody Therapy Compared With No Further Therapy After Surgery in Treating Patients With Stage II Colon Cancer
  ClinicalTrials.gov Identifier: NCT00002968 - Active, not recruiting
  stage II colon cancer; adenocarcinoma of the colon
  
• Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00084656 - Recruiting
  intraocular melanoma; Melanoma
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00052403 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00054574 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004115 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00016159 - Active, not recruiting
  adult acute myeloid leukemia in remission; childhood acute myeloid leukemia in remission; adult acute promyelocytic leukemia (M3); ...
  
• Monoclonal Antibody Therapy in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00002751 - Active, not recruiting
  leptomeningeal metastases
  
• Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00060138 - Active, not recruiting
  Hypercalcemia; stage IV breast cancer; recurrent breast cancer; bone metastases; Pain
  
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00032019 - Active, not recruiting
  adult diffuse large cell lymphoma; adult immunoblastic large cell lymphoma
  
• Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002734 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003868 - Active, not recruiting
  adult acute myeloid leukemia; childhood acute myeloid leukemia; secondary acute myeloid leukemia
  
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
  adult brain tumor
  
• Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00033423 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
  
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003797 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00014664 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent grade III follicular large cell lymphoma; ...
  
• Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement
  ClinicalTrials.gov Identifier: NCT00022906 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission
  ClinicalTrials.gov Identifier: NCT00002458 - Active, not recruiting
  recurrent neuroblastoma; disseminated neuroblastoma
  
• Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00033748 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
  ClinicalTrials.gov Identifier: NCT00004084 - Active, not recruiting
  Leukemia; Lymphoma
  
• Monoclonal Antibodies in Treating Patients with Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00056043 - Active, not recruiting
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
  
• Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00060346 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00004889 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00022321 - Active, not recruiting
  Refractory Anemia; de novo myelodysplastic syndromes; refractory anemia with ringed sideroblasts; ...
  
• Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00058435 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; ...
  
• Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00058292 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00039091 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; Melanoma; myelodysplastic and myeloproliferative disease; Non-small cell lung cancer; ...
  
• Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00001507 - Recruiting
  Breast Neoplasm; Neoplasm Metastasis
  
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006380 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
  ClinicalTrials.gov Identifier: NCT00059995 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; anaplastic large cell lymphoma; ...
  
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
  ClinicalTrials.gov Identifier: NCT00004074 - Active, not recruiting
  Cancer
  
• Monoclonal Antibody Therapy in Treating Patients With Progressive Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00093340 - Recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00007865 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Monoclonal Antibody Therapy After Allogeneic Stem Cell Transplantation in Treating Patients With Persistent or Progressive Cancer
  ClinicalTrials.gov Identifier: NCT00060372 - Recruiting
  Breast Cancer; Endocrine Cancer; female reproductive cancer; hematopoietic and lymphoid cancer; Neuroblastoma
  
• Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00004048 - Active, not recruiting
  medullary thyroid cancer
  
• Lymphocyte Therapy in Treating Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002589 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade non-Hodgkin's Lymphoma Following First Line CHOP
  ClinicalTrials.gov Identifier: NCT00022932 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00002482 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00072358 - Recruiting
  disseminated neuroblastoma; localized unresectable neuroblastoma; recurrent neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma
  
• Campath-1H and EPOCH to Treat non-Hodgkin's T- and NK-Cell Lymphomas
  ClinicalTrials.gov Identifier: NCT00069238 - Recruiting
  Lymphoma
  
• Oblimersen and Rituximab in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00054639 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Monoclonal Antibody Therapy in Patients With Primary or Metastatic Brain Tumors
  ClinicalTrials.gov Identifier: NCT00002754 - Active, not recruiting
  Astrocytoma; Brain Tumor; Oligodendroglioma; Glioblastoma Multiforme; Glioma
  
• Monoclonal Antibody SGN-30 in Treating Patients with Recurrent Or Refractory Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00118079 - Recruiting
  recurrent cutaneous T-cell lymphoma; anaplastic large cell lymphoma
  
• Expanded Access Study of Iodine-131 Anti-B1 Antibody
  ClinicalTrials.gov Identifier: NCT00022958 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004874 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent grade I follicular small cleaved cell lymphoma; ...
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006458 - Active, not recruiting
  Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; recurrent non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer
  
• Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00022893 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00091234 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00042913 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004087 - Active, not recruiting
  recurrent colon cancer; recurrent pancreatic cancer; stage IV pancreatic cancer; Stage IV rectal cancer; recurrent rectal cancer; ...
  
• Peripheral Stem Cell Transplantation Plus Monoclonal Antibody Therapy in Treating Patients With High-Risk Hematologic Cancer, Refractory Breast or Kidney Cancer, or Melanoma
  ClinicalTrials.gov Identifier: NCT00004143 - Active, not recruiting
  Breast Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; skin tumor
  
• Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00026312 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized resectable neuroblastoma; localized unresectable neuroblastoma
  
• RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00101972 - Recruiting
  Cancer
  
• Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
  ClinicalTrials.gov Identifier: NCT00058370 - Recruiting
  Adult Medulloblastoma; untreated childhood medulloblastoma
  
• Monoclonal Antibody hA20 in Treating Patients With Refractory Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00112970 - Recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin''s lymphoma; indolent or aggressive adult non-Hodgkin''s lymphoma
  
• Monoclonal Antibody SGN-30 in Treating Patients With Refractory or Recurrent Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00107133 - Recruiting
  recurrent adult Hodgkin's lymphoma; anaplastic large cell lymphoma
  
• Multiple Therapies in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00040872 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00014495 - Recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00096044 - Active, not recruiting
  refractory chronic lymphocytic leukemia
  
• Combination Chemotherapy, Monoclonal Antibody Therapy, and Surgery in Treating Women With Stage II, Stage III, or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006110 - Active, not recruiting
  stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004888 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00077116 - Active, not recruiting
  adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes
  
• Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00036868 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer